About Me
Cannabis has the opportunity to change lives...but the destigmatization is just beginning.
THE MISSION
By leveraging best practices, resources and infrastructure from sister industries like pharma and tobacco, engaging the consumer in the importance of quality of product and sustainability of footprint, cannabis can be offered as a safe and cost-effective alternative to many lab-developed medicines. Unfortunately for recreational use, medicinal use must precede, in order that the precedence of criminality and disenfranchisement of cannabis participants can be remediated.
WHO I AM
I've been a cannabis consumer as long as I've been working in the cGMP medical device and finished pharmaceutical industries; since 2006. I specialize in new site start-up, construction and commissioning/validation management, and facilities management, with respect to 21 CFRs 820 and 211, along with internationally applicable standards to those regs, like ISO9001, ISO13485. While I've been responsible for releasing to manufacturing about a dozen sites for both corporate and start-up customers, what I am most proud of having been the Quality Director for an ISO9001 CBD processor, with ground-breaking to ISO certification in 11months.
WHO YOU ARE
You don't have much time left to be counted among the First Movers in the USA medicinal MSO industry, and beyond onto the global stage. Globally and in the USA, industry change happens often and overcoming nigh impossible hurdles is the expectation. You'll need support that is ready for state and FDA audits, responding to competition upping stakes, training your organization to live the compliance mindset, and promptly staying ahead of the needs of your customers with creativity, tact, and continuous improvement. And above all, you need it done cost-effectively.
WHERE WILL WE GO?
In the past 20 years, I have accumulated much knowledge in the medicinal manufacturing industries to provide substantial value to the medicinal cannabis industry, and have a large, trusted network of similarly skilled medicinal cGMP peers. From navigating regs/standards, generating methods of operation that are reproducibly efficient and traceable, overcoming nonconformance and applying continuous improvement, the FDA and other federal regulatory bodies will expect this new medicinal product to behave like traditional medicinal products.
Don't re-invent the wheel! Acknowledge that the consumer of a medicinal product is a patient, and leverage the skill and talent of sister medicinal industries to provide the appropriate level of medicinal safety and consistency to improve the health and quality of life for your consumers.see less
City
Oakland
Pages
There are no results that match your search. Please try again.
